WELCOME TO THE DELVE BLOG.

Almost 70% of eligible patients live more than two hours away from sites. This geographical challenge has led sponsors to seek out ways to leverage technology solutions to conduct studies virtually, and even design decentralized clinical trials (DCTs) or hybrid studies, in order to expand their site’s reach—all while improving patient enrollment and retention.

Delve Health is a virtual research organization with the experience to help you plan and design decentralized (DCTs) and hybrid clinical trials. Our extensive network boasts access to one million medical professionals available for in-home visits and care, worldwide, when a specific study requires it. Our capabilities were designed to provide seamless integration while increasing patient compliance and retention, as well as providing study teams the experience they deserve.

Delve Health’s Clinical StudyPal allows users to design end-to-end hybrid and decentralized trials with no coding experience required. The system utilizes a set of tasks to help everyone involved in the study to better understand what needs to be completed while ensuring that deadline are met. Clinical StudyPal utilizes SMS technology to deliver the right message, at the right time, to the right person. Our solution Delve’s deeper to allow us to help with the following:

  • Patient screening
  • Patient enrollment
  • ePRO/eCOA
  • Patient device management
  • Randomization
  • eDiary entries and assignments
  • Data collection
  • Automated reminders to nudge patients
  • Completion alerts
  • Compliance reporting
  • Collect raw data from wearables and connected devices

ClinicalStudyPal has the ability to integrate into virtually any platform, making implementation seamless and relatively easy for study staff to effectively use “day one.”

Want to learn more? Schedule a consultation.

SIMILAR ARTICLES

real-time outcomes

Remote Patient Monitoring in Clinical Trials

In 1958, AT&T came out with the Bell 101 modem—the first commercial modem to transmit data via what would later be known as “the
Screen Shot Clinical researcher

Opinion: We Have Been Gifted a New Outlook on Increasing Patient Diversity, Compliance, and Retention in Clinical Trials

ACRP Clinical Researcher—June 21, 2022 Our own co-founder and CEO of Delve Health, Wessam Sonbol was published in the ACRP Clinical Researcher magazine. The
Patient Reported Outcomes

Conversations On the Ground—Traditional CROs vs. Virtual CROs

Delve Health’s upper management is currently attending the Drug Information Association’s (DIA) 2022 Global Annual Meeting in Chicago, Illinois. While we are taking all
Screen Shot afortiori development

Delve Health and Afortiori Development Announced Their Collaboration. What Does it Mean for Clinical Research?

Delve Health, a clinical research technology firm, and Afortiori Development, a clinical contract research organization (CRO), have announced an exciting partnership to expand patient
clinical trail day screenshot

Clinical Trials Day

May 20, 2022—Today is Clinical Trials Day. A day to recognize and raise awareness as to why clinical trials are so important to all
Patient Recruitment

Is Your Site Struggling to Recruit Patients for Upcoming Clinical Trials?

Almost 70% of eligible patients live more than two hours away from sites. This geographical challenge has led sponsors to seek out ways to
Previous
Next